---

Figure GPS-1: Proportion of all adults (aged 15 to 64) using cannabis daily or almost daily among current users (used in the last 30 days)

Figure GPS-2: Recent use (last year) of cannabis among young adults, 15 to 34 and 15 to 24 year age groups, measured by population surveys

Figure GPS-3: Current use (last month) of cannabis among youngest adults (aged 15 to 24), measured by national surveys

Figure GPS-4: Trends in recent use (last year prevalence) of cannabis among young adults (aged 15 to 34), measured by national surveys

Figure GPS-5: Recent use (last year) of amphetamines among young adults, 15 to 34 and 15 to 24, measured by population surveys

Figure GPS-6: Trends in recent use (last year) of amphetamines among young adults (aged 15 to 34), measured by population surveys

Figure GPS-7: Lifetime prevalence and recent (last year) use of ecstasy among young adults at selected ages, 15 to 34 and 15 to 24, measured by population surveys

Figure GPS-8: Trends in recent use (last year) of ecstasy among young adults (aged 15 to 34), measured by population surveys

Figure GPS-9: Recent use (last year) of cocaine among all young adults and young males (15 to 34 y.), measured by national surveys

Figure GPS-10: Trends in recent use (last year prevalence) of cocaine among young adults (aged 15 to 34), measured by population surveys

Figure GPS-11: Lifetime prevalence of cannabis among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, measured by population surveys

Figure GPS-12: Last year prevalence of cannabis among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, measured by national population surveys

Figure GPS-13: Current use (last 30 days) of cannabis among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group

Figure GPS-14: Trends in recent use (last year) of cannabis among younger adults (aged 15 to 24), measured by national surveys

Figure GPS-15: Lifetime prevalence of amphetamine use among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group

Figure GPS-16: Last year prevalence of amphetamines among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, in some EU countries

Figure GPS-17: Trends in recent use (last year prevalence) of amphetamines among younger adults (aged 15 to 24) as measured by national surveys

Figure GPS-18: Lifetime prevalence of ecstasy among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group

Figure GPS-19: Last year prevalence of ecstasy among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group

Figure GPS-20: Trends in recent use (last year prevalence) of ecstasy among younger adults aged 15 to 24 as measured by national surveys

Figure GPS-21: Lifetime prevalence of cocaine use among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, in some EU countries

Figure GPS-22: Last year prevalence of cocaine use among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, in some EU countries

Figure GPS-23: Recent use (last year) of amphetamines, ecstasy and cocaine among young adults – Part (i) Last year use among the 15 to 34 year age group

Figure GPS-23: Recent use (last year) of amphetamines, ecstasy and cocaine among young adults – Part (ii) Last year use among 15 to 24 year age group

Figure GPS-24: Continuation rates of cannabis (last year and last month use among lifetime users) in the general population, as measured by national surveys

Figure GPS-25: Recent use (last year) of cannabis by age group in United Kingdom, measured by national population surveys

Figure GPS-26: Trends in current use (last 30 days) of cannabis among young adults (aged 15 to 34) in some EU Member States and Norway, as measured by national population surveys

Figure GPS-27: Recent use (last year) of cannabis by age group in some Member States and candidate countries, measured by national population surveys – last survey available – Part (i) Last year prevalence in some of the EU-15 Member States

Figure GPS-27: Recent use (last year) of cannabis by age group in some Member States and candidate countries, measured by national population surveys – last survey available – Part (ii) Last year prevalence in some new EU Member States and candidate countries

Figure GPS-28: Continuation rates of cocaine (last year and last month use among lifetime users) in the general population, as measured by national surveys

Figure GPS-29: Continuation rates of ecstasy (last year and last month use among lifetime users) in the general population, as measured by national surveys

Figure GPS-30: Trends in recent amphetamines, ecstasy and cocaine use (last 12 months prevalence) among young adults (aged 15 to 34) in England and Wales

Figure GPS-31: Last year prevalence of amphetamine use (last survey available) in young adults (aged 15 to 34)

Figure GPS-32: Last year prevalence of ecstasy use (last survey available) among young adults (aged 15 to 34)

Figure GPS-33: Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) – Part (i) Cannabis use – lifetime experience, recent use (last 12 months) and current use (last 30 days)

Figure GPS-33: Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) – Part (ii) Cocaine, amphetamines and ecstasy use – lifetime experience, recent use (last 12 months) and current use (last 30 days)

Figure GPS-34: Comparison of drug use prevalence during last year by different user groups in the general population aged 15 to 34 – data for Spain, 1999

---